Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19.7M
-
Number of holders
-
264
-
Total 13F shares, excl. options
-
24.8M
-
Shares change
-
+50K
-
Total reported value, excl. options
-
$2.52B
-
Value change
-
+$4.67M
-
Put/Call ratio
-
1.44
-
Number of buys
-
128
-
Number of sells
-
-123
-
Price
-
$101.61
Significant Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q4 2016
308 filings reported holding LGND - LIGAND PHARMACEUTICALS INC - Common Stock as of Q4 2016.
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) has 264 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.8M shares
.
Largest 10 shareholders include BlackRock Fund Advisors (1.77M shares), VANGUARD GROUP INC (1.61M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.21M shares), Knott David M (998K shares), VICTORY CAPITAL MANAGEMENT INC (965K shares), STATE STREET CORP (849K shares), WELLS FARGO & COMPANY/MN (810K shares), CARDINAL CAPITAL MANAGEMENT LLC /CT (767K shares), OAK RIDGE INVESTMENTS LLC (667K shares), and BANK OF AMERICA CORP /DE/ (564K shares).
This table shows the top 264 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.